|4Apr 14, 4:12 PM ET

Icagen, Inc. 4

4 · Icagen, Inc. · Filed Apr 14, 2017

Insider Transaction Report

Form 4
Period: 2016-06-30
Transactions
  • Award

    Warrant

    2016-06-30+6,0006,000 total
    Exercise: $3.50From: 2016-06-30Exp: 2021-06-29Common Stock (6,000 underlying)
Footnotes (1)
  • [F1]Icagen, Inc. (the "Company") issued Units in a private placement offering (the "Offering") consummated in June 2016 with each Unit consisting of (i) a note in the principal amount of $10,000, and (ii) a five- year warrant to acquire 1,500 shares of Company's common stock, par value, $0.001 per share ("Common Stock"), at an exercise price of $3.50 per share. The Company retained Taglich Brothers, Inc. as the exclusive placement agent (the "Placement Agent") for the Offering. As compensation for the Placement Agent's services in the Offering, the Company (i) paid the Placement Agent a cash commission , and (ii) issued the Placement Agent warrants exercisable for an aggregate amount of 28,625 shares of Common Stock at an exercise price of $3.50 per share. The reporting person received the warrants disclosed herein as the designee of the Placement Agent.

Documents

1 file
  • 4
    f4063016palmieri_icageninc.xmlPrimary

    OWNERSHIP DOCUMENT